Atıf Formatları
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. F. Murrell Et Al. , "Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study," Journal of Investigative Dermatology , vol.144, no.8, pp.1762, 2024

Murrell, D. F. Et Al. 2024. Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study. Journal of Investigative Dermatology , vol.144, no.8 , 1762.

Murrell, D. F., Caux, F., Patsatsi, A., Hagino, O., Rudnicka, L., Vassileva, S., ... UZUN, S.(2024). Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study. Journal of Investigative Dermatology , vol.144, no.8, 1762.

Murrell, Dedee Et Al. "Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study," Journal of Investigative Dermatology , vol.144, no.8, 1762, 2024

Murrell, Dedee F. Et Al. "Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study." Journal of Investigative Dermatology , vol.144, no.8, pp.1762, 2024

Murrell, D. F. Et Al. (2024) . "Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study." Journal of Investigative Dermatology , vol.144, no.8, p.1762.

@article{article, author={Dedee F. Murrell Et Al. }, title={Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study}, journal={Journal of Investigative Dermatology}, year=2024, pages={1762} }